Recruiting OBSERVATIONAL NCT06402318

Passive Detection- SARS-CoV-2 (COVID-19) A&M Breathalyzer (PROTECT Kiosk) for Operational Medicine (COVID-19)

A Prospective, Non-interventional, Observational Clinical Validation Study to Analytically Validate the A&M Breathalyzer PROTECT Kiosk Breath Capture System.

Sponsor: Brooke Army Medical Center

Conditions COVID-19 COVID-19 Acute Respiratory Distress Syndrome COVID-19 Pneumonia COVID-19 Respiratory Infection SARS CoV 2 Virus

Interventions A&M Breathalyzer PROTECT Kiosk

Updated 5 times since 2024 Last updated: Dec 3, 2025 Started: Dec 27, 2023 Primary completion: Dec 31, 2025 Completion: Mar 30, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates COVID-19 and COVID-19 Acute Respiratory Distress Syndrome and is currently actively recruiting participants. Brooke Army Medical Center leads this study, which shows 5 recorded versions since 2023 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

5 versions recorded

Jan 2026 — Present [monthly]

Recruiting
Feb 2025 — Jan 2026 [monthly]

Recruiting
Sep 2024 — Feb 2025 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Jun 2024 — Jul 2024 [monthly]

Recruiting

First recorded

Dec 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Brooke Army Medical Center
Level 42 AI, Inc.
The Geneva Foundation
Uniformed Services University of the Health Sciences

Data source: The Geneva Foundation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Fort Sam Houston, United States